Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology
暂无分享,去创建一个
G. Lenz | E. Shumilov | T. Pabst | M. Zinkernagel | Y. Banz | U. Novak | D. Haase | Ulrike Bacher | M. Legros | N. Porret | P. Mazzeo | Lorenz Romagna
[1] C. Soussain,et al. Primary vitreoretinal lymphoma: A diagnostic and management challenge. , 2021, Blood.
[2] Justine R. Smith,et al. Intraocular Lymphoma , 2021, Ocular immunology and inflammation.
[3] T. Ushiku,et al. More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study , 2021, Ocular immunology and inflammation.
[4] Justine R. Smith,et al. Eye Involvement in Primary Central Nervous System Lymphoma. , 2020, Survey of ophthalmology.
[5] Xianjin Zhou,et al. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction , 2019, Ocular immunology and inflammation.
[6] Ana Helena Santos,et al. EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets. , 2019, Journal of immunological methods.
[7] Rajesh C. Dash,et al. Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without supporting morphologic features , 2018, Diagnostic cytopathology.
[8] M. Fukayama,et al. Clinical features and outcomes of secondary intraocular lymphoma , 2018, British journal of haematology.
[9] F. Fend,et al. How we diagnose and treat vitreoretinal lymphoma , 2016, British journal of haematology.
[10] Y. Matsuno,et al. Diagnostic efficacy of cell block method for vitreoretinal lymphoma , 2016, Diagnostic Pathology.
[11] J. Pulido,et al. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA , 2016, Retina.
[12] K. Bartz-Schmidt,et al. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. , 2015, Blood.
[13] H. Merle-Béral,et al. More Than a Masquerade Syndrome: Atypical Presentations of Vitreoretinal Lymphomas , 2014, Ocular immunology and inflammation.
[14] Justine R. Smith,et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. , 2011, The oncologist.
[15] C. Chang,et al. Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens. , 2009, Archives of pathology & laboratory medicine.
[16] J. Blay,et al. Primary CNS lymphoma with intraocular involvement , 2008, Neurology.
[17] H. Stein,et al. Primary intraocular lymphoma of T-cell type: report of a case and review of the literature , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[18] H. Stein,et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.
[19] P. Ruiz,et al. Diagnosis of intraocular lymphoma by flow cytometry. , 1997, American journal of ophthalmology.
[20] R. Evans,et al. Primary orbital lymphomas. , 1988, International journal of radiation oncology, biology, physics.
[21] Douglas C. Miller,et al. Primary central nervous system lymphoma. , 1988, Journal of neurosurgery.
[22] W. Green,et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. , 1987, Ophthalmology.
[23] E. Blumenthal,et al. Intraocular lymphoma. , 2007, Ophthalmology.